Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Counterfeit Ovulen-21 case

Executive Summary

According to FDA's March/April Case News the last defendent in the counterfeiting case, Sheldon Harwin, was sentenced on May 1 in Miami Federal Court to "11 consecutive years of incarceration." On March 14, Harwin was found guilty on five counts, which include conspiracy, causing the printing of counterfeit labels, and distribution of a counterfeit drug, FDA said. A total of seven persons have been prosecuted by FDA for distributing counterfeit Ovulen-21, the agency said. Two other defendents that were found guilty in 1987 are serving sentences of 24 years apiece ("The Pink Sheet" Dec. 5, 1988, T&G-17).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017492

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel